[New data on secondary prevention of myocardial infarction in Spain. Results of the PREVESE II study]. (Q30717128)

26 June 2017

[New data on secondary prevention of myocardial infarction in Spain. Results of the PREVESE II study]. (English)

1 reference

26 June 2017

myocardial infarction

1 reference

José A De Velasco

1

1 reference

26 June 2017

Juan Cosín

2

1 reference

26 June 2017

José Luis López-Sendón

3

1 reference

26 June 2017

Eduardo De Teresa

4

1 reference

26 June 2017

Manuel De Oya

5

1 reference

26 June 2017

Guillermo Sellers

6

1 reference

26 June 2017

language of work or name

Spanish

0 references

publication date

1 August 2002

1 reference

Revista Española de Cardiología

26 June 2017

1 reference

26 June 2017

55

1 reference

26 June 2017

8

1 reference

26 June 2017

801-809

1 reference

The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe

26 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976708-0

7 January 2021

Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976708-0

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976708-0

7 January 2021

beta Blockade after myocardial infarction: systematic review and meta regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976708-0

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976708-0

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976708-0

7 January 2021

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976708-0

7 January 2021

When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976708-0

7 January 2021

After 4S, CARE and LIPID--is evidence-based medicine being practised?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976708-0

7 January 2021

[Secondary prevention of myocardial infarction in Spain. The PREVERSE study]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976708-0

7 January 2021

Risk factor prevalence and drug treatment in coronary patients at hospital discharge. Results of a national multicenter registry (3C Program)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976708-0

7 January 2021

EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976708-0

7 January 2021

Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976708-0

7 January 2021

[Variability in the management and prognosis at short- and medium-term of myocardial infarct in Spain: the PRIAMHO study. Registration Project of Hospital Acute Myocardial Infarct]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976708-0

7 January 2021

Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976708-0

7 January 2021

Early statin treatment following acute myocardial infarction and 1-year survival

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2802%2976708-0

7 January 2021

10.1016/S0300-8932(02)76708-0

Identifiers

DOI

1 reference

26 June 2017

1 reference